SFI
BPMC

Susquehanna Fundamental Investments’s Blueprint Medicines BPMC Stock Holding History

Susquehanna Fundamental Investments’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,470
Closed -$445K – 582
2025
Q2 		$445K Hold
3,470
– – 0.01% 569
2025
Q1 		$307K Sell
3,470
-52,775
-94% -$5.15M ﹤0.01% 950
2024
Q4 		$4.91M Buy
+56,245
New +$5.15M 0.07% 330
2024
Q2 		$539K Hold
5,000
– – 0.01% 676
2024
Q1 		$474K Buy
+5,000
New +$429K 0.02% 473
2022
Q4 		– Sell
-10,174
Closed -$670K – 1219
2022
Q3 		$670K Buy
+10,174
New +$653K 0.01% 931
2022
Q1 		$1.1M Buy
17,174
+1,224
+8% +$87.9K 0.02% 800
2021
Q4 		$1.71M Buy
+15,950
New +$1.67M 0.04% 473
2021
Q2 		– Sell
-14,257
Closed -$1.39M – 1656
2021
Q1 		$1.39M Buy
14,257
+11,157
+360% +$1.11M 0.02% 771
2020
Q4 		$348K Hold
3,100
– – 0.01% 1218
2020
Q3 		$287K Sell
3,100
-400
-11% -$30.8K 0.01% 1079
2020
Q2 		$273K Buy
+3,500
New +$237K 0.01% 765

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna Fundamental Investments's BPMC Position: Q3 2025 in Review

Susquehanna Fundamental Investments sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 3,470 shares — an estimated $445K sold.

Susquehanna Fundamental Investments first reported a position in BPMC in Q2 2020 and held it in 12 quarters. The position peaked at $4.91M in Q4 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Susquehanna Fundamental Investments reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 3,470 Blueprint Medicines shares in Q3 2025, an estimated $445K.
  • Susquehanna Fundamental Investments first reported a position in Blueprint Medicines in Q2 2020 and held it in 12 quarters.
  • Susquehanna Fundamental Investments's Blueprint Medicines position peaked at $4.91M in Q4 2024.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2025, filed 14 Nov 2025.